ReviewCurrent diabetes reports2022

Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists.

Scott Cohen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.